UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3887

2022

Volltextzugriff (PDF)

Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference

Intensive care medicine, 2021-10, Vol.47 (10), p.1063-1077

2021

Volltextzugriff (PDF)

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)

Haematologica (Roma), 2018-11, Vol.103 (11), p.e519-e521

2018

Volltextzugriff (PDF)

SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report

Clinical case reports, 2021-07, Vol.9 (7), p.n/a

2021

Volltextzugriff (PDF)

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

Blood, 2012-12, Vol.120 (25), p.5089-5090

2012

Volltextzugriff (PDF)

Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?

Current opinion in oncology, 2016-09, Vol.28 (5), p.390-397

2016

Volltextzugriff (PDF)

Hepatosplenic T-cell lymphoma: treatment challenges

Current opinion in oncology, 2021-09, Vol.33 (5), p.406-411

2021

Volltextzugriff (PDF)

The Decreased Susceptibility of Bcr/Abl Targets to NK Cell-Mediated Lysis in Response to Imatinib Mesylate Involves Modulation of NKG2D Ligands, GM1 Expression, and Synapse Formation

Journal of Immunology, 2006-01, Vol.176 (2), p.864-872

2006

Volltextzugriff (PDF)

A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing

The Journal of infectious diseases, 2023-11, Vol.228 (11), p.1505-1515

2023

Volltextzugriff (PDF)

First Case of Pleural Empyema Caused by Aureimonas altamirensis: An Unusual Opportunistic Pathogen to be Aware of in Hemato-Oncologic Patients

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S213-S214

2019

Volltextzugriff (PDF)

Thyroid nocardiosis: Case report and review of the literature

Transplant infectious disease, 2021-08, Vol.23 (4), p.e13594-n/a

2021

Volltextzugriff (PDF)

Early Discontinuation of Lenalidomide in Patients with Relapsing or Refractory Multiple Myeloma: Predictive Factors for Stopping in the Real Life

Blood, 2016-12, Vol.128 (22), p.4504-4504

2016

Volltextzugriff (PDF)

Unspecific Neurologic Alteration After Hematopoietic Stem Cell Transplantation

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S229-S229

2019

Volltextzugriff (PDF)

Second case of Chitinophaga spp bacteremia in humans

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S234-S235

2019

Volltextzugriff (PDF)

Correlation between Chemotherapy Toxicities and Better Outcome, A Question to Think About in Hematologic Malignancies

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18, p.S192-S192

2018

Volltextzugriff (PDF)

Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium

Acta clinica belgica (English ed. Online), 2017-12, Vol.72 (6), p.429-433

2017

Volltextzugriff (PDF)

Long-Term Overall and Event-Free Survival after RIC Allogeneic Transplantation in Acute Leukemias in a Single Centre - Impact of Age and Donor Type?

Blood, 2015-12, Vol.126 (23), p.5454-5454

2015

Volltextzugriff (PDF)

Dyspnea and Fever in an Allogeneic Stem Cell Recipient

Clinical infectious diseases, 2015-01, Vol.60 (1), p.157-158

2015

Volltextzugriff (PDF)

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial

The Lancet. Haematology, 2023-11, Vol.10 (11), p.e879-e889

2023

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(33)
Berichte
(1)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(18)
Hematology
(8)
Female
(7)
Immunology
(7)
Male
(7)
Middle Aged
(7)
Adult
(6)
Hematopoietic Stem Cell Transplantation
(6)
Stem Cell Transplantation
(6)
Aged
(5)
Oncology
(5)
Patients
(5)
Life Sciences
(4)
Transplantation, Homologous
(4)
Acute Myeloid Leukemia
(3)
Adolescent
(3)
Antineoplastic Agents - Therapeutic Use
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy

Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference

Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)

SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?

Hepatosplenic T-cell lymphoma: treatment challenges

The Decreased Susceptibility of Bcr/Abl Targets to NK Cell-Mediated Lysis in Response to Imatinib Mesylate Involves Modulation of NKG2D Ligands, GM1 Expression, and Synapse Formation

A Herpes Simplex Virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in a Patient With Immunodeficiency and Confirmed by Gene Editing

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial

First Case of Pleural Empyema Caused by Aureimonas altamirensis: An Unusual Opportunistic Pathogen to be Aware of in Hemato-Oncologic Patients

Exploring the Heterogeneity of Response to Blinatumomab in High-Risk Philadelphia-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: An Analysis from the QUEST Sub-Study of the Graall-2014/B Trial

Thyroid nocardiosis: Case report and review of the literature

Early Discontinuation of Lenalidomide in Patients with Relapsing or Refractory Multiple Myeloma: Predictive Factors for Stopping in the Real Life

Unspecific Neurologic Alteration After Hematopoietic Stem Cell Transplantation

Second case of Chitinophaga spp bacteremia in humans

Correlation between Chemotherapy Toxicities and Better Outcome, A Question to Think About in Hematologic Malignancies

Efficacy and Toxicity of Donor Lymphocyte Infusions in the Management of Mixed Donor-Recipient Chimerism Following Allogeneic Stem Cell Transplantation for Lymphoid Malignancies:- a Study of the LWP-EBMT

Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium

Long-Term Overall and Event-Free Survival after RIC Allogeneic Transplantation in Acute Leukemias in a Single Centre - Impact of Age and Donor Type?

Donor Lymphocyte Infusions for the Treatment of Relapsed Non-Hodgkin Lymphoma Following Allogeneic Stem Cell Transplantation: A LWP-EBMT Study

Dyspnea and Fever in an Allogeneic Stem Cell Recipient

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial

Oxygenation strategy during acute respiratory failure in immunocompromised patients

Suchergebnisse filtern